FDA raises sprinkled drug bead size after big pharma criticism
The FDA has raised its limit on the bead size for drugs delivered by sprinkling after big pharma firms criticised its draft guidance.
The FDA has raised its limit on the bead size for drugs delivered by sprinkling after big pharma firms criticised its draft guidance.
A US contract testing laboratory has received a FDA warning letter for allowing all its employees to use the same username and password.
More evidence Russia’s Ministry of Health (MoH) may be getting better at approving trials emerged this week - at least when it comes to international studies.
Celerion and Ricera Biosciences have launched a new joint venture to provide a cost-cutting one-stop-shop solution for companies developing and commercialising biosimilars.
DSM is continuing its search for CMO partners to help it recover from the halving of fourth quarter pharma earnings.
The UN has urged Governments to crack down on the growing number of fake drugs being sold online.
The drug excipient industry wants the Chinese Pharmacopoeia Committee (CPC) to harmonise monographs with international compendia says IPEC Americas.